Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hokkaido Sugar is a Japanese manufacturer specializing in the production of beet sugar and high-purity functional ingredients derived from sugar beets. The company is a leading global supplier of Raffinose, a prebiotic trisaccharide used in pharmaceuticals, infant formula, and health foods to support intestinal health. Additionally, they produce Betaine, which is utilized in the cosmetics industry for its moisturizing properties and in nutritional supplements. As a subsidiary of Mitsui DM Sugar Holdings, Hokkaido Sugar employs advanced extraction and purification technologies to provide GMP-compliant ingredients for the life sciences and healthcare sectors. Their high-purity Raffinose is also a critical component in organ preservation solutions and serves as a stabilizer for biological products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hokkaido Sugar.